Additional European Equity News
Boohoo (BOO LN) - Frasers Group (FRAS LN) discloses 10.4% (Prev. 9.1%) stake in the Co. as of Aug 31. (Newswires)
Direct Line (DLG LN) - Issues statement on past business review. Redress estimate at GBP 30mln. Review following implemeentation of FCA pricing practices regulation from 1 Jan 2022. (Newswires)
GSK (GSK LN) - GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps. (GSK)
Reckitt (RKT LN) - Licht to take over as CEO on 1 October 2023. (Newswires)
Salzgitter (SZG GY) – Following the Aurubis announcement around their FY EBT guidance, Salzgitter has suspended its earnings guidance for the FY, guidance will be adjusted accordingly when Aurubis updates. Due to Salzgitter holding a 29.99% stake in Aurubis. (Newswires) -4.8% in pre-market trade
SAS (SAS SS) - Q3 (SEK): Op 1.58bln (Exp. 1.54bln), Revenue 13.2bln (Exp. 13.4bln). Making progress on Chapter 11 process in the US, to increase capacity this winter YY. (Newswires)
Saint-Gobain (SGO FP) - Divests its glass processing business in Slovakia, which generated EUR 20mln in 2022 and employs 150 people. (Newswires)
Aurubis (NDA GY) downgraded to Neutral from Outperform at Oddo Securities
Groupe Bruxelles Lambert (GBLB BB) initiated with Buy at Kepler Cheuvreux
Repsol (REP SM) upgraded to Overweight from Equal Weight at Morgan Stanley
Pernod Ricard (RI FP) reiterated with Outperform at Credit Suisse
Pernod Ricard (RI FP) reiterated with Overweight at Barclays
01 Sep 2023 - 07:09- EquitiesResearch Sheet- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts